Bimekizumab: Phase Ib data

Top-line data from a double-blind, European Phase Ib trial in 52 patients with psoriatic arthritis who had inadequate responses

Read the full 195 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE